Tuberculosis (TB)

WHO report 2008
Global tuberculosis control

Chapter 3 Financing TB control

Implementing the Stop TB Strategy at the scale required to achieve the MDG, Stop TB Partnership and World Health Assembly targets for global TB control (see also Chapters 1 and Chapter 2) requires accurate budgeting of the financial resources required, mobilization of the necessary funding and spending of available money such that TB control outcomes are improved. Analysis of budgets and funding for TB control was introduced into the annual WHO report on global TB control in 2002, and expenditures have been reported on since 2004.

In this report, we provide our latest assessment of financing for TB control. As with the previous two chapters, emphasis is given to the 22 HBCs, but analyses for all countries that have reported financial data are included. The chapter is structured in eight major sections, which are:

  • Data reported to WHO in 2007. This section describes the number of countries that reported financial data and the share of the global number of TB cases accounted for by these countries.
  • NTP budgets, available funding and funding gaps. This section analyses changes in NTP budgets in HBCs for the period 2002–2008, including presentation of budgets broken down by funding source and line item.
  • Total costs of TB control. This section estimates the total costs of TB control, which include the resources used for diagnosis of TB and treatment of patients within the general health-care system (e.g. primary health-care staff and infrastructure) as well as the costs included in NTP budgets. Total costs in the years 2002–2008 are estimated for HBCs, and for all countries by WHO region in 2008.

  • Comparisons with the Global Plan. In this section, total funding requirements for TB control based on country reports are compared with the total funding requirements estimated in the Global Plan. This is done for the period 2006–2008 for HBCs, and for 2008 for all countries.

  • Per patient costs and budgets. Using the total budget and cost data provided in earlier sections of this chapter and and forecasts of patients to be treated in 2008, this section provides a summary of per patient budgets and costs in each HBC in 2008.

  • Expenditures compared with available funding and changes in cases treated. This section investigates the extent to which available funding was spent in 2006, as well as the relationship between changes in funding for TB control and changes in the number of new cases detected and treated in DOTS programmes.

  • The Global Fund contribution to TB control. With the Global Fund the largest single source of donor financing for TB control, this section includes the latest data on its contribution to funding for TB control.

  • How can funding gaps for TB control be closed? This section discusses why funding gaps for TB control persist. It gives particular attention to the resources available from the Global Fund, and what is needed to close the gap between currently available funding and the funding needs set out in the Global Plan.

Further details about the financing of TB control in the 22 HBCs are provided in Annex 1.